M&A market and life sciences companies

The global M&A market declined significantly during the Covid-19 pandemic. This has also been reflected in transactions in the life sciences sector. However, our expert Christian Klingbeil assumes that the transaction market will recover quite quickly – first acquisitions can already be observed again. In this video, he explains how the transaction strategy of life sciences companies looks like in the new reality.

The current overview of transactions in the life sciences and chemicals industry can be found in our newsletter Deal Capsule Chemicals and Deal Capsule Life Sciences.